Targeting unmet needs in eye care.
Wolfring Therapeutics is a clinical-stage company developing new treatments for common eye conditions that today have no approved drug therapy.
Contact usAbout
Focused on overlooked conditions
Many patients with chronic eye conditions are left with procedures, workarounds, or nothing at all. We develop simple, patient-friendly therapies for these gaps, with an efficient path through clinical development.
Unmet need first
We pursue conditions that affect quality of life and have no approved pharmacologic treatment.
Well-characterized science
We build on established pharmacology to move efficiently from concept to clinic.
Designed for patients
Our products are designed for easy, self-administered use at home.
Pipeline
Development pipeline
Program
Preclinical
Pre-IND
IND
Phase 2a
Phase 2b
Phase 3
NDA
EPI-001Topical ophthalmic · Phase 2b complete
CompletePlanned
Contact
Get in touch
For partnering and investment inquiries.